LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 131 pages found matching glaxo- Avandia and FDA now subject of Congressional Hearing
Jun-6-07 Washington, DC Diabetes drug Avandia is making the news again this week, on two fronts. On June 6, 2007 a Congressional committee will hold a meeting to address the safety of Avandia, and the question of whether federal drug regulators (read the FDA) have paid close enough attention to its potential risks. The hearing before the House Committee on Ove... - Avandia Maker Tried to Silence Doctor who had Concerns
Jun-5-07 Washington, DC: A noted diabetes specialist who first raised the red flag on the diabetic drug Avandia in 2000, claims that the drug manufacturer attempted to gag his criticism and quash his findings, to the point where a colleague refused to write prescriptions for Avandia because GlaxoSmithKline was giving his friend such a hard time. Worse, alleged... - Glaxo Stuck in Damage Control Mode Over Avandia
Jun-4-07 Washington, DC: On May 23, 2007, the Associated Press reported that more than 6 million people worldwide have taken Avandia (rosiglitazone), made by GlaxoSmithKline, to control blood sugar since it came on the market in 1999, and about 1 million patients in the US currently use the drug. However, studies recently analyzed at the Cleveland Clinic shows A... - High Anxiety over Avandia Report
May-30-07 Washington, DC Even the United States Senate is getting involved in the worried reaction to the report published last Monday claiming the popular diabetes drug Avandia raises the risk and severity of heart attacks. On May 21 the New England Journal of Medicine reported that an analysis of 42 separate studies on the drug concluded that Avandia rais... - Avandia Concerns Known Since 2000
May-24-07 Chapel Hill, NC The diabetes drug Avandia , which has been in the news this week following a report in the New England Journal of Medicine (NEJM) over concerns of a link to heart problems, continues to percolate throughout the prescription drug world - and telling information, lurking beneath the surface almost since the drug fist came onto the market, is... - April 2007 Big Pharma Litigation Update - Drugs (Part II)
Apr-12-07 Washington, DC: The anti-epileptic drug, Depakote (valproate), marketed by Abbott Laboratories, is one of the most heavily prescribed medications for off-label use. Experts say the evidence of harm caused by Depakote is just beginning to emerge. According to Harrisburg, Pennsylvania psychiatrist, Dr Stefan Kruszewski, a recognized expert on psychotropic... - Trail of Paxil Suicides Leads To GlaxoSmithKline
Feb-14-07 Washington, DC: On January 29, 2007, BBC-One broadcast, "Secrets of the Drug Trials," a Panorama program based on an investigation by reporter, Shelley Jofre, which revealed how GlaxoSmithKline misled doctors into prescribing Paxil off-label to children, even after its own clinical trials found that kids could become suicidal when taking the drug. The... - Zyprexa Injury Clock Keeps Ticking Away
Feb-2-07 San Jose, CA The on-going legal battle over the disclosure of secret Eli Lilly documents that reveal the serious health risks associated with Zyprexa and the company's off-label promotion of the drug involves a matter of grave public concern. But observers on the sidelines of this courtroom circus say the conduct of the judge in helping Lilly keep d... - GlaxoSmithKline Defamed With Truth About Paxil
Jan-31-07 London, UK: GlaxoSmithKline has labeled the allegations made in a Panorama television program that said the company had suppressed the results of clinical trials that showed Paxil was ineffective and caused children to become suicidal "defamatory." According to the January 30, 2007, Guardian, an official at the company said Glaxo had looked into takin... - Daniel Troy - Godfather of Big Pharma Protection Racket
Dec-27-06 Washington, DC: In hindsight, its now more than apparent that Daniel Troy, who fought against stricter prescription drug laws in private practice, was appointed Chief Counsel at the FDA for one reason, to serve as Godfather in setting up a protection racket for Big Pharma. On August 20, 2001, when President Bush made him Chief Counsel, Mr Troy became th... - Weighing Benefits of SSRIs Against Suicide Risk
Dec-8-06 Washington, DC: Before the FDA's Psychopharmacologic Drugs Advisory Committee begins the discussion at the December 13, 2006, public hearing on the suicide risks associated with selective serotonin inhibitor antidepressants , it should get honest with the audience and openly admit that the SSRIs do not even work. Medical professionals maintain that in... - FDA Advisory Committee Schedules Hearing on SSRIs and Suicide
Dec-5-06 Washington DC: The FDA's Psychopharmacologic Drugs Advisory Committee will hold a public hearing on December 13, 2006, to review the adult selective serotonin reuptake inhibitor (SSRI) studies on the increased risk of suicide associated with the antidepressants. The panel is expected to vote on whether the risk of suicidality in adults should be inclu... - Glaxo Writing Checks Left and Right to Settle Paxil Legal Battles
Dec-3-06 Madison County, IL: GlaxoSmithKline is no doubt looking forward to the New Year because the end of this one is becoming costlier by the month. On November 1, 2006, the Associated Press reported that Glaxo had agreed to pay $63.8 million to settle a class action lawsuit with allegations that Glaxo promoted Paxil for use with children and adolescents wh... - Ending FDA's Love Affair With Big Pharma
Nov-22-06 Washington, DC: With the Democrats back in power, critics say officials at the FDA and representatives of Big Pharma had better plan on spending much of their time testifying on Capital Hill in Congressional hearings in 2007. Democrats have spelled out their plans to change how the administration chooses experts to sit on FDA advisory panels and put a... - FDA's Preemption Gift to Big Pharma
Nov-20-06 Washington, DC: An item sure to end up on the chopping block with the Democrats back in power, is the Bush administration's multi-billion dollar gift to Big Pharma, that bars people who have been injured by drugs approved by the FDA from suing the drug's maker in state courts. Under the FDA's federal preemption position, victims injured by dangerous dru... - Paxil: A Fatal Link to Coronary Birth Defects
Nov-17-06 Todd, NC When Bonnie was concerned about staying on Paxil she was told not to worry as it was classified as Category B. Tragically, her son died from heart birth defects ; five years later she discovered that Paxil is now Category D. (In December 2005, the FDA asked Glaxo Smith Kline, the manufacturer of Paxil, to change the pregnancy category to D,... - FDA and Big Pharma Gang Up On Joe Citizen
Nov-6-06 Washington, DC: The botched safety processes at the FDA have had an extremely negative impact on the nation's public health and tens of thousands of people have died as a result of its negligent handling of the Vioxx debacle alone. Americans today can no more trust what's in their medicine cabinets than could the pioneers in the 1800s who filled their m... - Glaxo gets Hit with another Paxil Birth Defects Lawsuit
Oct-17-06 Denver, CO Two years ago, little Eric Jackson was born with persistent pulmonary hypertension, a life-threatening lung disorder in which an infant's arteries to the lungs remain constricted after birth, limiting the amount of blood flow to the lungs and oxygen in the bloodstream. Persistent pulmonary hypertension (PPHN) is associated with substantial in... - 2005 Profitable Year for Whistleblowers
Oct-1-06 Washington, DC The year 2005 was a very good year for Whistleblowers . According to a report by the Department of Health and Human Services, a grand total of $136,756,946 was awarded to Whistleblowers who filed q The Act requires that recoveries from health care investigations, including criminal fines, forfeitures, civil settlements and judgments, and... - Uphill Battle - Warning Pharma Customers about Dangers of SSRIs
Sep-29-06 Recent concerns about the adverse effects of selective serotonin reuptake inhibitor antidepressants (SSRIs) have focused on suicide risks. However, a new study published in the September 2006 journal, Public Library of Science (PLoS), reports that in addition to self-harm, the drugs can also cause some patients to become violent and homicidal. Professor...